51 results
424B3
DMAC
DiaMedica Therapeutics Inc.
18 Jul 24
Prospectus supplement
5:28pm
Department and the IRS indicated that they continue to study the appropriate treatment of working capital for purposes of the passive asset test
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
26 Jun 24
DiaMedica Therapeutics Announces $11.8 Million
8:16am
of the U.S. Treasury Department (“OFAC”).
(oo) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property … , the U.S. Department of Labor, the Pension Benefit Guaranty Corporation or any other federal or state governmental agency or any foreign regulatory agency
8-K
EX-99.2
DMAC
DiaMedica Therapeutics Inc.
26 Jun 24
Regulation FD Disclosure
8:01am
of the Department of Obstetrics and Gynecology, University of Melbourne, and Director of Perinatal Medicine at Mercy Hospital for Women.
“Gaining access
424B3
v488 iynt
10 Jul 23
Prospectus supplement
4:16pm
8-K
EX-10.1
63nle3iouf9ib
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
8-K
EX-10.1
qha fhf6mj5vgvc3
29 Jun 22
Entry into a Material Definitive Agreement
4:30pm
424B3
fqta8kdb umu
15 Oct 21
Prospectus supplement
6:32am
8-K
EX-10.1
d20vfrhk
27 Sep 21
DiaMedica Therapeutics Announces $30 Million
8:45am
8-K
EX-1.1
6q8ihr25u1hemjx3wyk
10 Aug 20
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
12:00am
8-K
EX-99.1
g9bbrj vg
10 Aug 20
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
12:00am
8-K
EX-99.2
34cali2b
13 May 20
DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a
4:35pm
8-K
EX-1.1
t28i1jeo
13 Feb 20
DiaMedica Announces Pricing of Public Offering of Common Shares
4:31pm
424B5
mwrp4wxc
11 Feb 20
Prospectus supplement for primary offering
5:31pm